Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription 10.06.2019 1 Am J Respir Cell Mol Biol 1 Am J Respir Crit Care Med 1 Ann Oncol 1 Ann Thorac Surg 2 BMJ 1 Clin Cancer Res 7 Clin Lung Cancer 3 Eur J Cardiothorac Surg 1 Eur Respir J 2 Int J Cancer 1 Int J Oncol 1 Int J Radiat Oncol Biol Phys 1 J Cancer Res Clin Oncol 2 J Clin Oncol 1 J Thorac Cardiovasc Surg 3 J Thorac Oncol 1 N Engl J Med 2 Oncol Rep 1 Oncologist 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Respir Cell Mol Biol

1. REYFMAN PA, Gottardi CJ
   IPF and Lung Cancer: Finding Similarities within Differences.
   Am J Respir Cell Mol Biol. 2019 Jun 5. doi: 10.1165/rcmb.2019-0172.
   PubMed     Text format    
   
   

   
   Am J Respir Crit Care Med

2. GARMENDIA I, Pajares MJ, Hermida-Prado F, Ajona D, et al
   YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
   Am J Respir Crit Care Med. 2019 Jun 5. doi: 10.1164/rccm.201807-1292.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

3. PASTORINO U, Silva M, Sestini S, Sabia F, et al
   Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
   Ann Oncol. 2019 Jun 5. pii: 5511622. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Thorac Surg

4. GAO HJ, Jiang ZH, Gong L, Ma K, et al
   Video-assisted Versus Thoracotomy Sleeve Lobectomy for Lung Cancer: a Propensity Matched Analysis.
   Ann Thorac Surg. 2019 Jun 1. pii: S0003-4975(19)30715.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

5. MAHASE E
   Lung cancer: audit shows improvement in surgery survival.
   BMJ. 2019;365:l4024.
   PubMed     Text format    
   
   
6. NEAL RD, Sun F, Emery JD, Callister ME, et al
   Lung cancer.
   BMJ. 2019;365:l1725.
   PubMed     Text format    
   
   

   
   Clin Cancer Res

7. CHALISHAZAR MD, Wait SJ, Huang F, Ireland AS, et al
   MYC-driven small cell lung cancer is metabolically distinct and vulnerable to arginine depletion.
   Clin Cancer Res. 2019 Jun 4. pii: 1078-0432.CCR-18-4140.
   PubMed     Text format     Abstract available
   
   

   
   Clin Lung Cancer

8. PINSOLLE J, Mondet J, Duruisseaux M, d'Alnoncourt S, et al
   A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
   Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30105.
   PubMed     Text format    
   
   
9. KIM R, Keam B, Hahn S, Ock CY, et al
   First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.
   Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30113.
   PubMed     Text format     Abstract available
   
   
10. IKARI T, Sakakibara-Konishi J, Yamamoto G, Kitai H, et al
    Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30106.
    PubMed     Text format    
    
    
11. MENDOZA DP, Stowell J, Muzikansky A, Shepard JO, et al
    Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30110.
    PubMed     Text format     Abstract available
    
    
12. RADES D, Motisi L, Veninga T, Conde-Moreno A, et al
    Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Apr 26. pii: S1525-7304(19)30085.
    PubMed     Text format     Abstract available
    
    
13. SCHILD SE, Zhao L, Wampfler JA, Daniels TB, et al
    Small-cell Lung Cancer in Very Elderly (>/= 80 Years) Patients.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30111.
    PubMed     Text format     Abstract available
    
    
14. MEZQUITA L, Benito A, Ruano-Ravina A, Zamora J, et al
    Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2019 May 3. pii: S1525-7304(19)30100.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cardiothorac Surg

15. YUN JK, Lee GD, Choi S, Kim HR, et al
    Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511574. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
16. STILES BM, Mao J, Harrison S, Lee B, et al
    Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511701. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
17. MARIJIC P, Walter J, Schneider C, Schwarzkopf L, et al
    Cost and survival of video-assisted thoracoscopic lobectomy versus open lobectomy in lung cancer patients: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2019 Jun 3. pii: 5510143. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Eur Respir J

18. SEIJO LM, Soriano JB, Peces-Barba G
    New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD.
    Eur Respir J. 2019;53.
    PubMed     Text format    
    
    

    
    Int J Cancer

19. LIU YN, Tsai MF, Wu SG, Chang TH, et al
    Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32487.
    PubMed     Text format     Abstract available
    
    
20. BECKER N, Motsch E, Trotter A, Heussel CP, et al
    Lung cancer mortality reduction by LDCT screening - results from the randomised German LUSI trial.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32486.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

21. LIU Y, Xie S, Zeng J, Song X, et al
    Adenylyl cyclaseassociated protein 1targeted nanoparticles as a novel strategy for the treatment of metastatic nonsmall cell lung cancer.
    Int J Oncol. 2019 Jun 6. doi: 10.3892/ijo.2019.4822.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

22. BADIYAN SN, Robinson CG, Bradley JD
    Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem?
    Int J Radiat Oncol Biol Phys. 2019;104:590-592.
    PubMed     Text format    
    
    

    
    J Cancer Res Clin Oncol

23. PARK CK, Kim JE, Kim MS, Kho BG, et al
    Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2019 Jun 1. pii: 10.1007/s00432-019-02944.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

24. GARON EB, Hellmann MD, Rizvi NA, Carcereny E, et al
    Five-Year Overall Survival for Patients With Advanced NonSmall-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
    J Clin Oncol. 2019 Jun 2:JCO1900934. doi: 10.1200/JCO.19.00934.
    PubMed     Text format     Abstract available
    
    
25. RANGACHARI D, Costa DB
    From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer.
    J Clin Oncol. 2019 Jun 2:JCO1901207. doi: 10.1200/JCO.19.01207.
    PubMed     Text format    
    
    

    
    J Thorac Cardiovasc Surg

26. ALTORKI N, Lee B
    Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30903.
    PubMed     Text format    
    
    

    
    J Thorac Oncol

27. RUTKOWSKI J, Saad ED, Burzykowski T, Buyse M, et al
    Chronological Trends in Progression-free, Overall and Post-progression Survival in First-line Therapy for Advanced Non-small-cell Lung Cancer.
    J Thorac Oncol. 2019 Jun 1. pii: S1556-0864(19)30415.
    PubMed     Text format     Abstract available
    
    
28. LANGER CJ, Redman MW, Wade JL 3rd, Aggarwal C, et al
    Brief Report: SWOG S1400B (NCT02785913), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).
    J Thorac Oncol. 2019 May 31. pii: S1556-0864(19)30414.
    PubMed     Text format     Abstract available
    
    
29. SHEPSHELOVICH D, Xu W, Lu L, Fares A, et al
    Body mass index (BMI), BMI change, and overall survival in small cell and non-small cell lung cancer patients: a pooled analysis of the International Lung Cancer Consortium.
    J Thorac Oncol. 2019 Jun 1. pii: S1556-0864(19)30416.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

30. YU D, Blair JEA
    A STEMI Mimic.
    N Engl J Med. 2019;380:e41.
    PubMed     Text format    
    
    

    
    Oncol Rep

31. LIU Q, Huo Y, Zheng H, Zhao J, et al
    Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of nonsmall cell lung cancer cells via the HMGB1/RAGE axis and the NFkappaB/STAT3 pathway.
    Oncol Rep. 2019 May 30. doi: 10.3892/or.2019.7176.
    PubMed     Text format     Abstract available
    
    
32. OKITA R, Maeda A, Shimizu K, Nojima Y, et al
    Effect of platinumbased chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death1 ligand 1 and HLA class I in nonsmall cell lung cancer.
    Oncol Rep. 2019 Jun 3. doi: 10.3892/or.2019.7185.
    PubMed     Text format     Abstract available
    
    

    
    Oncologist

33. FINTELMANN FJ, Troschel FM, Kuklinski MW, McDermott S, et al
    Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer.
    Oncologist. 2019 May 31. pii: theoncologist.2019-0158.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

34. LIU J, Liu S, Deng X, Rao J, et al
    MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1.
    PLoS One. 2019;14:e0217652.
    PubMed     Text format     Abstract available
    
    
35. NAKAMURA H, Fujii K, Gupta V, Hata H, et al
    Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes.
    PLoS One. 2019;14:e0217105.
    PubMed     Text format     Abstract available
    
    
36. RICE SJ, Liu X, Wang HG, Belani CP, et al
    EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer.
    PLoS One. 2019;14:e0217657.
    PubMed     Text format     Abstract available
    
    
37. BYCHKOV M, Shenkarev Z, Shulepko M, Shlepova O, et al
    Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of alpha7 nicotinic acetylcholine receptors.
    PLoS One. 2019;14:e0217339.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: